Medicus Pharma Ltd. Common Stock (MDCX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Medicus Pharma Ltd. Commo...

NASDAQ: MDCX · Real-Time Price · USD
2.09
0.00 (0.00%)
At close: Sep 09, 2025, 3:59 PM
2.08
-0.24%
After-hours: Sep 09, 2025, 07:40 PM EDT

Medicus Pharma Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-11.18M -4.73M -978.42K -1.44M
Interest Income
104.41K 10.72K -575.45K -575.45K
Pretax Income
-11.16M -5.31M -1.69M -2.06M
Net Income
-10.62M -5.31M -1.69M -2.06M
Selling & General & Admin
7.65M 2.46M 332.03K 258.01K
Research & Development
3.53M 193.58K 646.38K 1.18M
Other Expenses
n/a 2.07M n/a n/a
Operating Expenses
11.18M 4.73M 978.42K 1.44M
Interest Expense
317.54K 595.54K 526.83K 115.41K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.18M 4.73M 978.42K 1.44M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
9.62M 3.48M 1.93M 8.05M
Shares Outstanding (Diluted)
9.62M 3.48M 8.05M 8.05M
EPS (Basic)
-1.1 -1.53 -0.88 -0.26
EPS (Diluted)
-1.1 -1.53 -0.21 -0.26
EBITDA
-10.62M -2.66M -1.17M -1.94M
EBIT
-10.25M -2.66M -1.17M -1.94M
Depreciation & Amortization
-366.74K 2.07M -187.14K -498.47K